Rabbani, N.; Adaikalakoteswari, A.; Larkin, J.R.; Panagiotopoulos, S.; MacIsaac, R.J.; Yue, D.K.; Fulcher, G.R.; Roberts, M.A.; Thomas, M.; Ekinci, E.;
et al. Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease. Int. J. Mol. Sci. 2023, 24, 152.
https://doi.org/10.3390/ijms24010152
AMA Style
Rabbani N, Adaikalakoteswari A, Larkin JR, Panagiotopoulos S, MacIsaac RJ, Yue DK, Fulcher GR, Roberts MA, Thomas M, Ekinci E,
et al. Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease. International Journal of Molecular Sciences. 2023; 24(1):152.
https://doi.org/10.3390/ijms24010152
Chicago/Turabian Style
Rabbani, Naila, Antonysunil Adaikalakoteswari, James R. Larkin, Sianna Panagiotopoulos, Richard J. MacIsaac, Dennis K. Yue, Gregory R. Fulcher, Matthew A. Roberts, Merlin Thomas, Elif Ekinci,
and et al. 2023. "Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease" International Journal of Molecular Sciences 24, no. 1: 152.
https://doi.org/10.3390/ijms24010152
APA Style
Rabbani, N., Adaikalakoteswari, A., Larkin, J. R., Panagiotopoulos, S., MacIsaac, R. J., Yue, D. K., Fulcher, G. R., Roberts, M. A., Thomas, M., Ekinci, E., & Thornalley, P. J.
(2023). Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease. International Journal of Molecular Sciences, 24(1), 152.
https://doi.org/10.3390/ijms24010152